A Oneindia Venture
Click it and Unblock the Notifications
Anthem Biosciences Ltd. IPO
Anthem Biosciences Ltd., established in 2006, operates in the Pharmaceuticals sector. The company's IPO opened on July 14, 2025 and closed on July 16, 2025, with an issue price of ₹570. The Anthem ... Read more
IPO Timeline
-
14 Jul 2025Bidding Starts
-
16 Jul 2025Bidding Ends
-
17 Jul 2025Allotment Finalization
-
21 Jul 2025Listing
About Anthem Biosciences Ltd.
We are an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (“CRDMO”) with fully integrated operations spanning across drug discovery, development and manufacturing with integrated New Chemical Entity (“NCE”) and New ... Read more
Anthem Biosciences Ltd. IPO Reservation
| Investors Category | Shares Offered |
|---|---|
| Anchor Investors | 1,78,25,000 (29.92%) |
| Employee Reserved | 1,58,653 (0.27%) |
| Non Institutional Investors | 89,12,500 (14.96%) |
| Qualified Institutional Buyers (QIBs) | 1,18,83,333 (19.95%) |
| Retail Individual Investors (RIIs) | 2,07,95,833 (34.91%) |
Anthem Biosciences Ltd. Financial Information
| Year End | Revenue | PAT | Reserves & Surplus |
|---|---|---|---|
| 31 Mar 2025 | 1,950.09 Cr | 506.19 Cr | 2,361.40 Cr |
| 31 Mar 2024 | 1,488.06 Cr | 374.78 Cr | 1,821.26 Cr |
| 31 Mar 2023 | 1,134.30 Cr | 323.87 Cr | 1,627.52 Cr |
Anthem Biosciences Ltd. Background
-
2006Incorporation of our Company.
-
2007Commenced operations of our Company at Unit I and set up a custom synthesis plant with a capacity of 6 KL.
-
2008Commencement of the discovery biology services with a fermentation capacity of 2 KL.
-
2010Expanded the custom synthesis plant set up at Unit I increasing its capacity from 6 KL to 24 KL.
-
2013Received the first USFDA audit approval for Unit I.
-
2016Set up a high potent lab at Unit I - Bommasandra Facility.
-
2017Our Company, pursuant to an order dated November 30, 2017, amalgamated with Anthem Cellutions (India) Private Limited by way of an acquisition of 100% of its share capital.
Set up a solid phase peptide synthesis GMP lab with a capacity of 6 KL at Unit 1.
Commenced operations of our Company at Unit II and set up an automated GMP compliant custom synthesis plant with a capacity of 128 KL and a fermentation plant with a capacity of 80 KL.
Received the second USFDA audit approval for Unit I.
-
2018Anthem Cellutions (India) Private Limited amalgamated into our Company.
-
2019Received the third USFDA approval for Unit I.
Set up a flow chemistry lab at Unit I.
-
2020Commenced operations in biological facility 2 earmarked for a specific client.
-
2022Expanded the custom synthesis plant set up at Unit II increasing its capacity to 246 KL.
-
2023Received the first USFDA audit approval and first therapeutic goods administration audit for Unit II.
Addition of Oligonucleotide lab in Unit I.
Set a cGMP scale continuous flow manufacturing facility for Unit II.
-
2024Received the:
• second USFDA audit approval for Unit II;
• first ANVISA audit approval for Unit I(1); and
• first ANVISA audit approval for Unit II(1).
Commenced operations of Neoanthem Lifesciences Private Limited, at Unit III designed as a chemistry lab and customer synthesis pilot plant for development, technology transfer and scale-up projects.
Fermentation capacity expanded to 140 KL at Unit II.
Conversion of our Company into a public limited company, under the name “Anthem Biosciences Limited”.
-
2025Received the fourth USFDA approval for Unit I.
1. Ccarry out the Offer for Sale of up to [?] Equity Shares of face value of ? 2 each by the Selling Shareholders aggregating up to ? 33,950.00 million
2. Achieve the benefits of listing the Equity Shares on the Stock Exchanges
| Pricing Details | BSE | NSE |
|---|---|---|
| Issue Price | ₹ 570.00 | ₹ 570.00 |
| Open | ₹ 723.10 | ₹ 723.05 |
| Low | ₹ 723.05 | ₹ 723.05 |
| High | ₹ 746.70 | ₹ 747.00 |
| Last Trade | ₹ 730.35 | ₹ 730.35 |
1. Ajay Bhardwaj
2. Ganesh Sambasivam
3. K Ravindra Chandrappa
4. Ishaan Bhardwaj
According to the F&S Report, the global pharmaceutical industry is projected to grow to U.S.$ 2,076.0 billion by 2029, and CROs and CDMOs are increasingly combining their services to establish integrated CRDMO business models. According to the F&S Report, the Indian CRDMO industry is ... Read more
FAQs
When does Anthem Biosciences Ltd. IPO opens and closes?
What is the size of Anthem Biosciences Ltd. IPO?
What is the price range of Anthem Biosciences Ltd. IPO?
What is the minimum investment and lot size required for the Anthem Biosciences Ltd. IPO?
When is Anthem Biosciences Ltd. IPO listing date?
What is the objective of Anthem Biosciences Ltd. IPO?
2. Achieve the benefits of listing the Equity Shares on the Stock Exchanges
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
Anthem Biosciences IPO GMP Hits 27%, Oversubscribed 800% On Day 3; Last Chance To Apply, Bid or Skip? -
Anthem Biosciences IPO Day 1: How Much Rs 3,395 Crore IPO Has Been Subscribed On Monday? Should You Buy? -
CMPDI IPO Lists at 7% Discount on NSE, BSE; Weak Demand Keeps Stock Under Pressure Despite Mild Recovery -
CMPDI IPO Allotment Today: Did You Get Shares? Check Status Now on KFin, NSE, BSE -
Powerica IPO Off to Slow Start: GMP Up 1.2%, But Subscription Stuck at 0.01x; Is It Worth Applying? -
CMPDI IPO Underwhelms: Day 2 Subscription At 10%, No Movement In GMP; What's Behind The Weak Demand? -
Upcoming IPOs Next Week: CMPDI, Sai Parenteral, Powerica, Vivid Electromech, More | Check Full List -
XED Executive Development IPO: GIFT City Sees First IPO; Price Band, Issue Size | All You Need to Know -
Skyways Air IPO vs CMPDI IPO: Full Comparison of Price Band, GMP, Lot Size, Listing & Allotment Date -
Coal India's CMPDI IPO GMP Shows 11% Listing Gain Potential; Everything You Need To Know -
Big Change in IPO Rules: Govt Updates Minimum Public Offer Norms for for IPO-bound Firms -
Raajmarg Infra Investment Trust InvIT IPO Closed with 1323% Subscription on Day 3; GMP Remains Flat
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Sign in with Google- Male
- Female
- Others
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+